Orthopedic tax pains (Sherry Slater @ Journal Gazette)
With U.S. sales to grow costlier, one company looks abroad
Nick Deeter’s five-year-old company is growing, but he’s the one in pain.
The founder and chairman of OrthoPediatrics Corp. knows the financially responsible thing to do is market his products overseas. Not only do U.S. sales involve significant upfront costs, but they will soon be subject to a 2.3 percent medical device tax scheduled to take effect Jan. 1, 2013. International sales are exempt from the tax and upfront costs.
Across the medical devices industry, executive...
